Kurt Zimmermann

2.7k citations

66 papers · 1.7k indexed · h-index 24

Radiology, Nuclear Medicine and Imaging top 2%
- Radiopharmaceutical Chemistry and Applications 15
- Monoclonal and Polyclonal Antibodies Research 10
Food Science top 2%
- Probiotics and Fermented Foods 11
Oncology top 10%
- Peptidase Inhibition and Analysis 4
Biotechnology top 5%
Molecular Biology top 10%
- Gut microbiota and health 8
- Protein Degradation and Inhibitors 4
Endocrinology, Diabetes and Metabolism
- Growth Hormone and Insulin-like Growth Factors 5
Organic Chemistry
- Synthetic Organic Chemistry Methods 4

Co-authors: Jürgen Grünberg Michael Honer P. August Schubiger Ilse Novak‐Hofer Roger Schibli Simone Jeger Alain Blanc Peter Hunziker
Cited by: Radiology, Nuclear Medicine and Imaging Food Science Oncology
Partner nations: Germany Switzerland United States

In The Last Decade

Kurt Zimmermann

66 papers receiving 1.6k citations

Peers

Countries citing papers authored by Kurt Zimmermann

Since Specialization

Citations

This map shows the geographic impact of Kurt Zimmermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kurt Zimmermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kurt Zimmermann more than expected).

Fields of papers citing papers by Kurt Zimmermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kurt Zimmermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kurt Zimmermann. The network helps show where Kurt Zimmermann may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kurt Zimmermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kurt Zimmermann Line = papers co-authored together Kurt Zimmermann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Co-opting the E3 ligase KLHDC2 for targeted protein degradation by small molecules Christopher M. Hickey,Katherine M. Digianantonio,Kurt Zimmermann,Alicia Harbin,Connor Quinn,Avani Patel,Peter C. Gareiss,Amanda Chapman,Bernadette Tiberi,Jennifer Dobrodziej,John Corradi,Angela Cacace,David R. Langley,Miklós Békés	2024	29
2	A randomized controlled trial of effects of open-label placebo compared to double-blind placebo and treatment-as-usual on symptoms of allergic rhinitis Michael Schaefer,Kurt Zimmermann,Paul Enck	2023	6
3	Enterococci as Intestinal Microbiota: Investigation of Characteristics and Probiotic Potential in Isolates from Adults and Breast-Fed Infants Maryam Rahmani,Fereshteh Saffari,Eugen Domann,Kurt Zimmermann,Ladan Langroudi,Shahla Mansouri	2022	3
4	Evaluating Ligands for Ubiquitin Ligases Using Affinity Beads Jennifer Dobrodziej,Hanqing Dong,Kurt Zimmermann,Christopher M. Hickey	2021	1
5	Probiotic Potential and Safety Evaluation of Enterococcus faecalis OB14 and OB15, Isolated From Traditional Tunisian Testouri Cheese and Rigouta, Using Physiological and Genomic Analysis Olfa Baccouri,Amine M. Boukerb,Leila Ben Farhat,Arthur Constant Zébré,Kurt Zimmermann,Eugen Domann,Mélyssa Cambronel,Magalie Barreau,Olivier Maillot,Isabelle Rincé,Cécile Muller,Mohamed Néjib Marzouki,Marc Feuilloley,Ferid Abidi,Nathalie Connil	2019	82
6	Secretory expression of biologically active human Herpes virus interleukin-10 analogues in Escherichia colivia a modified Sec-dependent transporter construct Sarah Förster,Manuela Brandt,Dorothea S. Mottok,Anke Zschüttig,Kurt Zimmermann,Frederick R. Blattner,Florian Gunzer,Christoph Pöhlmann	2013	6
7	Proteomics as a Quality Control Tool of Pharmaceutical Probiotic Bacterial Lysate Products Günter Klein,Joost P. Schanstra,Janosch Hoffmann,Harald Mischak,Justyna Siwy,Kurt Zimmermann	2013	21
8	DOTA-Functionalized Polylysine: A High Number of DOTA Chelates Positively Influences the Biodistribution of Enzymatic Conjugated Anti-Tumor Antibody chCE7agl Jürgen Grünberg,Simone Jeger,Dikran Sarko,Patrick Dennler,Kurt Zimmermann,Walter Mier,Roger Schibli	2013	25
9	L1‐CAM‐targeted antibody therapy and ¹⁷⁷Lu‐radioimmunotherapy of disseminated ovarian cancer Eliane Fischer,Jürgen Grünberg,Susan Cohrs,Alexander Höhn,Karin Waldner‐Knogler,Simone Jeger,Kurt Zimmermann,Ilse Novak‐Hofer,Roger Schibli	2011	29
10	Insulin-like growth factor-1 receptor (IGF-1R) kinase inhibitors: SAR of a series of 3-[6-(4-substituted-piperazin-1-yl)-4-methyl-1H-benzimidazol-2-yl]-1H-pyridine-2-one Upender Velaparthi,Mark G. Saulnier,Mark D. Wittman,Peiying Liu,David B. Frennesson,Kurt Zimmermann,Joan M. Carboni,Marco M. Gottardis,Aixin Li,Ann Greer,Wendy Clarke,Zheng Yang,Krista Menard,Francis Y. Lee,George L. Trainor,Dolatrai M. Vyas	2010	16
11	Production and separation of ''non-standard'' PET nuclides at a large cyclotron facility: the experiences at the Paul Scherrer Institute in Switzerland. Alexander Höhn,Kurt Zimmermann,E Schaub,Walter Hirzel,P. A. Schubiger,Roger Schibli	2008	26
12	2-(1H-Imidazol-4-yl)ethanamine and 2-(1H-pyrazol-1-yl)ethanamine side chain variants of the IGF-1R inhibitor BMS-536924 Mark G. Saulnier,David B. Frennesson,Mark D. Wittman,Kurt Zimmermann,Upender Velaparthi,David R. Langley,Charles Struzynski,Xiaopeng Sang,Joan M. Carboni,Aixin Li,Ann Greer,Zheng Yang,Praveen Balimane,Marco M. Gottardis,Ricardo M. Attar,Dolatrai M. Vyas	2008	20
13	Balancing oral exposure with Cyp3A4 inhibition in benzimidazole-based IGF-IR inhibitors Kurt Zimmermann,Mark D. Wittman,Mark G. Saulnier,Upender Velaparthi,David R. Langley,Xiaopeng Sang,David B. Frennesson,Joan M. Carboni,Aixin Li,Ann Greer,Marco M. Gottardis,Ricardo M. Attar,Zheng Yang,Praveen Balimane,Lorell Discenza,Dolatrai M. Vyas	2008	17
14	Comparative genomic analysis for the presence of potential enterococcal virulence factors in the probiotic Enterococcus faecalis strain Symbioflor 1 Eugen Domann,Torsten Hain,Rohit Ghai,André Billion,Carsten Kuenne,Kurt Zimmermann,Trinad Chakraborty	2007	91
15	Discovery and initial SAR of 3-(1H-benzo[d]imidazol-2-yl)pyridin-2(1H)-ones as inhibitors of insulin-like growth factor 1-receptor (IGF-1R) Upender Velaparthi,Mark D. Wittman,Peiying Liu,Karen M. Stoffan,Kurt Zimmermann,Xiaopeng Sang,Joan M. Carboni,Aixin Li,Ricardo M. Attar,Marco M. Gottardis,Ann Greer,ChiehYing Y. Chang,Bruce L. Jacobsen,John S. Sack,Yax Sun,David R. Langley,Balu Balasubramanian,Dolatrai M. Vyas	2007	35
16	Evaluation of 177Lu-DOTA-labeled aglycosylated monoclonal anti-L1-CAM antibody chCE7: influence of the number of chelators on the in vitro and in vivo properties Karin Knogler,Jürgen Grünberg,Ilse Novak‐Hofer,Kurt Zimmermann,P. August Schubiger	2006	40
17	Radiometal Labeling of Antibodies and Antibody Fragments for Imaging and Therapy Ilse Novak‐Hofer,Robert Waibel,Kurt Zimmermann,Roger Schibli,Jürgen Grünberg,Kerry Chester,Andrea Murray,Benny K. C. Lo,Alan C. Perkins,P.A. Schubiger	2004	4
18	Imaging of renal carcinoma xenografts with 64 Cu-labelled anti-L1-CAM antibody chCE7 Ilse Novak‐Hofer,Michael Honer,Simon M. Ametamey,J�rgen Gr�nberg,J. Missimer,Kurt Zimmermann,P. August Schubiger	2003	3
19	Peptide Linkers Lead to Modification of Liver Metabolism and Improved Tumor Targeting of Copper-67-labeled Antibody Fragments Ilse Novak‐Hofer,Kurt Zimmermann,P. August Schubiger	2001	10
20	Development of a simple and selective separation of 67Cu from irradiated zinc for use in antibody labelling: A comparison of methods R. Schwarzbach,Kurt Zimmermann,Peter Bläuenstein,Alan Р. Smith,P. August Schubiger	1995	70

About Kurt Zimmermann

Kurt Zimmermann is a scholar working on Radiology, Nuclear Medicine and Imaging, Food Science and Toxicology, having authored 66 papers that have together received 1.7k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (15 papers), Probiotics and Fermented Foods (11 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Gut microbiota and health (8 papers), Growth Hormone and Insulin-like Growth Factors (5 papers), Peptidase Inhibition and Analysis (4 papers), Protein Degradation and Inhibitors (4 papers) and Synthetic Organic Chemistry Methods (4 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (607 citations), Food Science (342 citations) and Oncology (347 citations). Kurt Zimmermann has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Jürgen Grünberg, Michael Honer, P. August Schubiger, Ilse Novak‐Hofer, Roger Schibli, Simone Jeger, Alain Blanc, Peter Hunziker, Harriet Struthers and Simon M. Ametamey.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact